April 13, 2016 / 1:42 PM / 2 years ago

Valeant CEO Pearson agrees to depose before Senate committee

April 13 (Reuters) - Valeant Pharmaceuticals International Inc’s outgoing Chief Executive Michael Pearson will depose before the Senate Special Committee on Aging to comply with a congressional subpoena, the committee said.

Pearson will depose on April 18, ahead of an April 27 hearing, the committee said in a statement on Wednesday.

Valeant said on Monday that it had asked Pearson to cooperate with the committee after he failed to show up at a hearing on Friday related to an investigation into drug pricing. (Reporting by Ankur Banerjee in Bengaluru; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below